Raptor Pharmaceuticals (RPTP) Bullish View Reiterated at Cowen Following Expanded Label
Tweet Send to a Friend
Cowen analyst Ritu Baral reiterated an Outperform rating and $24 price target on Raptor Pharmaceuticals (NASDAQ: RPTP) after the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE